Updated Nov 4, 2026FDA and CMS public dataIndependent · free · not health advice
GxRadar
Drugs/Digoxin 125 mcg tablet
Heart

Digoxin 125 mcg tablet

Public data on digoxin from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.

$0.1233
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-56%
change over five years
peak $1.0894 in 2014-03
15
approved generic applications (ANDAs) on record for Digoxin
9 with a product still marketed · first 1975
Not listed
in FDA's current shortage list
no matching FDA shortage entries

NADAC per unit, monthly

DIGOXIN 125 MCG TABLET
Show as table
MonthNADAC per unit ($)
2013-110.10639
2014-021.08716
2014-051.04985
2014-081.01324
2014-110.99273
2015-020.97906
2015-050.92602
2015-080.86211
2015-110.80421
2016-020.77570
2016-050.71531
2016-080.68003
2016-110.60243
2017-020.57321
2017-050.49411
2017-080.47992
2017-110.43966
2018-020.43885
2018-050.40602
2018-080.41486
2018-110.34553
2019-020.31749
2019-050.30938
2019-080.33070
2019-110.34849
2020-020.32166
2020-050.32870
2020-080.32273
2020-110.29017
2021-020.31262
2021-050.30251
2021-080.29779
2021-110.28051
2022-020.24275
2022-050.24075
2022-080.22416
2022-110.20150
2023-020.18055
2023-050.17193
2023-080.18433
2023-110.19381
2024-020.18672
2024-050.12691
2024-080.14781
2024-110.15187
2025-020.13724
2025-050.13602
2025-080.10741
2025-110.11160
2026-020.11260
2026-050.11759
2026-080.12897
2026-110.12334

Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.

Recall records mentioning digoxin

openFDA enforcement records, by year reported.

20242
20232
20151
20142

7 records since 2012. A record is one product or lot, not one recall event. Combination products that contain digoxin are included.

What these numbers mean

NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.

Most recent recall records

Class IIITerminated
Digoxin tablets
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-0443-2024
Class IIITerminated
Digoxin tablets
Reason category: Sterility / contamination
FDA recall number D-0389-2024
Class IITerminated
Digoxin tablets
Reason category: Labeling or packaging error
FDA recall number D-1170-2023
Class ITerminated
Digoxin tablets
Reason category: Labeling or packaging error
FDA recall number D-1169-2023
Class IITerminated
Digoxin product
Reason category: Sterility / contamination
FDA recall number D-630-2015

Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.

Articles that mention digoxin

10 GxRadar articles cite or discuss this drug.

PRICE INDEX · 2014 = 100
Price histories · Data story · 6 min

The generics that cost pharmacies more than they did in 2014

Most generics in GxRadar's 47-drug basket got cheaper. Seven cost pharmacies more than in January 2014, led by furosemide at 2.8 times its 2014 price. What federal cost and shortage data show, drug by drug.

Benchmarks & how prices are set · Explainer · 5 min

Why the same generic costs different amounts at different pharmacies

Cash quotes for the same three heart-failure generics ranged from $12 to almost $398 across 175 pharmacies in one 2016 study. Federal cost data show how little of that price is the drug itself.

Equivalence & alternatives · Explainer · 5 min

Narrow therapeutic index drugs and the tighter test for their generics

Warfarin, levothyroxine, phenytoin and a few other drugs face a stricter generic test scaled to the brand's own variability. How it works, which drugs it covers and where state law adds rules.

2013
Market economics · History · 6 min

The generic price spikes of 2013 to 2015

Generic prices fell overall in the early 2010s, yet 315 established generics at least doubled in price. What GAO and HHS investigators found, what CMS price data show, and what Congress changed.

Market economics · Explainer · 6 min

The economics of making a generic

What it costs to bring a generic to market and make it, how competition drives the price down, and why federal analyses find many launches unprofitable years later, using ASPE, FDA and NADAC data.

Medicare & Medicaid · Explainer · 6 min

How Medicaid pays for generic drugs

Generics are 86 percent of Medicaid prescriptions and 14 percent of its gross drug spending. How the rebate program, the 2015 generic inflation rebate and Federal Upper Limits shape what Medicaid pays.